Servicio de Alergología e Inmunología, CM ASISA Lobatón, Cádiz, Spain.
University of Cordoba, Cordoba, Spain.
Sci Rep. 2021 Dec 8;11(1):23585. doi: 10.1038/s41598-021-03005-4.
Accessibility to more precise diagnostic techniques such as component resolved diagnostics (CRD), provides us with an important advance in diagnostic aspects as well as treatment. The subject of this study aims to better understand the profiles of sensitization to Der p 1, Der p 2 and Der p 23 and to know to what extent their use could help us in optimizing the decision-making for their treatment with Specific Immunotherapy. Cross-sectional study of subjects older than 5 years, diagnosed with allergy to HDM using skin prick test and sIgE, with symptoms of rhinitis and/or asthma. Total and specific IgE was determined to D. pteronyssinus, nDer p 1, rDer p 2 and rDer p 23 using ImmunoCAP. 240 patients were recruited (97.1% rhinitis and 46.25% rhinitis and asthma). Four different phenotypes were observed: positive or negative for sIgE nDer p 1 and/or IgE rDer p 2. 17% of these patients sIgE were double negative for Der p 1 and Der p 2 (increasing with age and with significantly lower sIgE levels than the rest of the groups). Using ROC curves, value less than 2.18 KU/L for D. pteronyssinus sIgE gave us a sensitivity and specificity of 0.882 and 0.985, respectively, to double negative IgE nDer p 1 and IgE rDer p 2 group. Despite positive SPT and sIgE to D. pteronyssinus, 17% of the studied population is IgE nDer p 1 and IgE rDer p 2 double negative, with a cut-off value of 2.18 KU/L, which is very relevant for taking of decisions in prescription of AIT. The double positive population sIgE nDer p 1 and IgE rDer p 2 is associated with asthma compared to the other groups and this does not seem to be influenced by IgE rDer p 23.
对更精确的诊断技术(如组分分辨诊断(CRD))的访问为我们提供了在诊断和治疗方面的重要进展。本研究的目的是更好地了解对 Der p 1、Der p 2 和 Der p 23 的致敏谱,并了解它们的使用在多大程度上可以帮助我们优化特异性免疫治疗的决策。 对使用皮肤点刺试验和 sIgE 诊断为 HDM 过敏、有鼻炎和/或哮喘症状的 5 岁以上患者进行横断面研究。使用 ImmunoCAP 测定 D. pteronyssinus、nDer p 1、rDer p 2 和 rDer p 23 的总 IgE 和特异性 IgE。共招募了 240 名患者(97.1%为鼻炎患者,46.25%为鼻炎和哮喘患者)。观察到四种不同的表型:sIgE nDer p 1 和/或 IgE rDer p 2 阳性或阴性。这些患者中有 17%的 sIgE 对 Der p 1 和 Der p 2 双阴性(随年龄增长而增加,与其他组相比 sIgE 水平显著降低)。使用 ROC 曲线,D. pteronyssinus sIgE 值小于 2.18 KU/L 时,对双阴性 IgE nDer p 1 和 IgE rDer p 2 组的敏感性和特异性分别为 0.882 和 0.985。尽管有阳性的皮试和 D. pteronyssinus sIgE,但研究人群中仍有 17%为 IgE nDer p 1 和 IgE rDer p 2 双阴性,截断值为 2.18 KU/L,这对于 AIT 处方决策非常重要。与其他组相比,双阳性 sIgE nDer p 1 和 IgE rDer p 2 人群与哮喘相关,而且似乎不受 IgE rDer p 23 的影响。